PT1373503E - ''factores neurotróficos'' - Google Patents
''factores neurotróficos'' Download PDFInfo
- Publication number
- PT1373503E PT1373503E PT02706759T PT02706759T PT1373503E PT 1373503 E PT1373503 E PT 1373503E PT 02706759 T PT02706759 T PT 02706759T PT 02706759 T PT02706759 T PT 02706759T PT 1373503 E PT1373503 E PT 1373503E
- Authority
- PT
- Portugal
- Prior art keywords
- neurotrophic factors
- neublastin
- polypeptides
- methods
- antibodies
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title 1
- 102000007072 Nerve Growth Factors Human genes 0.000 title 1
- 239000003900 neurotrophic factor Substances 0.000 title 1
- 102100026376 Artemin Human genes 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/804,615 US20020055467A1 (en) | 1998-07-06 | 2001-03-12 | Novel neurotrophic factors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1373503E true PT1373503E (pt) | 2008-02-26 |
Family
ID=25189406
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02706759T PT1373503E (pt) | 2001-03-12 | 2002-03-12 | ''factores neurotróficos'' |
| PT07120461T PT1930439E (pt) | 2001-03-12 | 2002-03-12 | Factores neurotróficos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT07120461T PT1930439E (pt) | 2001-03-12 | 2002-03-12 | Factores neurotróficos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020055467A1 (enExample) |
| EP (2) | EP1930439B1 (enExample) |
| JP (2) | JP3738008B2 (enExample) |
| CN (1) | CN1268744C (enExample) |
| AT (2) | ATE378353T1 (enExample) |
| AU (1) | AU2002240943B2 (enExample) |
| CA (1) | CA2440767C (enExample) |
| CY (1) | CY1111750T1 (enExample) |
| DE (1) | DE60223511T2 (enExample) |
| DK (2) | DK1373503T3 (enExample) |
| ES (2) | ES2296899T3 (enExample) |
| NZ (1) | NZ528790A (enExample) |
| PT (2) | PT1373503E (enExample) |
| SI (2) | SI1930439T1 (enExample) |
| WO (1) | WO2002072826A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| WO2000004050A2 (en) * | 1998-07-14 | 2000-01-27 | Janssen Pharmaceutica N.V. | Neurotrophic growth factor |
| MXPA03005721A (es) * | 2000-12-22 | 2004-04-21 | Genentech Inc | Uso novedoso de artemina, un miembro de la familia de ligandos gdnf. |
| US7442370B2 (en) * | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
| US7276580B2 (en) * | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
| CA2442159C (en) * | 2001-03-28 | 2011-08-23 | Biogen, Inc. | Treatment using neublastin polypeptides |
| JP2005516949A (ja) * | 2001-12-19 | 2005-06-09 | リジュン・ワン | Ｇｄｎｆの骨格筋へのアデノ随伴ウイルス媒介性のデリバリー |
| JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Ｊｘ日鉱日石エネルギー株式会社 | 潤滑油組成物 |
| EP2301960A3 (en) * | 2003-01-31 | 2011-08-03 | Biogen Idec MA Inc. | Polymer conjugates of mutated neublastin |
| NZ543365A (en) | 2003-04-18 | 2009-02-28 | Biogen Idec Inc | Polymer-conjugated glycosylated neublastin |
| DE602004019524D1 (de) | 2003-06-10 | 2009-04-02 | Nsgene As | Verbesserte sezernierung von neublastin |
| US7598059B2 (en) * | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
| WO2005039643A2 (en) | 2003-10-20 | 2005-05-06 | Nsgene A/S | In vivo gene therapy of parkinson's disease |
| DE602005022082D1 (de) * | 2004-08-19 | 2010-08-12 | Biogen Idec Inc | Rückfaltung von proteinen der transforming-growth-factor-beta-familie |
| EP1786454B1 (en) * | 2004-08-19 | 2010-07-21 | Biogen Idec MA Inc. | Neublastin variants |
| EP1937295A2 (en) * | 2005-10-11 | 2008-07-02 | NS Gene A/S | Treatment of retinopathies using gfr 3 agonists |
| TWI501774B (zh) * | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| ES2450065T3 (es) * | 2006-03-01 | 2014-03-21 | Biogen Idec Ma Inc. | Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF |
| US8329655B2 (en) | 2007-05-01 | 2012-12-11 | Biogen Idec Ma Inc. | Methods for increasing vascularization |
| US20110135648A1 (en) * | 2007-08-08 | 2011-06-09 | Biogen Idec Ma Inc. | Anti-neublastin antibodies and uses thereof |
| US20100247437A1 (en) * | 2007-10-01 | 2010-09-30 | Vgx Pharmaceuticals, Llc | Materials and methods for the delivery of biomolecules to cells of an organ |
| CA2813013C (en) * | 2010-10-01 | 2019-10-22 | Nsgene A/S | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| JP7235230B2 (ja) * | 2018-05-17 | 2023-03-08 | ヘリックスミス カンパニー， リミテッド | 化学療法－誘発末梢神経病症と関連した神経病症性痛みの治療 |
| CN117279657A (zh) | 2021-05-18 | 2023-12-22 | 日本株式会社Ltt生物医药 | 用于治疗或预防伴随抗癌剂给药的障碍的医药组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184200B1 (en) * | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
| KR100587556B1 (ko) | 1996-05-08 | 2006-06-08 | 바이오겐 아이덱 엠에이 인코포레이티드 | 신경 및 신장 증식을 자극하기 위한 ＲＥＴ리간드（ＲｅｔＬ) |
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| US6284540B1 (en) * | 1998-09-29 | 2001-09-04 | Washington University | Artemin, a novel neurotrophic factor |
| JP2002531128A (ja) * | 1998-12-09 | 2002-09-24 | アムジエン・インコーポレーテツド | 神経栄養因子ｇｒｎｆ４ |
| PT1185648E (pt) * | 1999-06-22 | 2007-06-29 | Genentech Inc | Métodos e composições para a inibição do crescimento de células neoplásicas. |
-
2001
- 2001-03-12 US US09/804,615 patent/US20020055467A1/en not_active Abandoned
-
2002
- 2002-03-12 SI SI200230954T patent/SI1930439T1/sl unknown
- 2002-03-12 AT AT02706759T patent/ATE378353T1/de active
- 2002-03-12 CA CA2440767A patent/CA2440767C/en not_active Expired - Fee Related
- 2002-03-12 EP EP07120461A patent/EP1930439B1/en not_active Expired - Lifetime
- 2002-03-12 NZ NZ528790A patent/NZ528790A/en not_active IP Right Cessation
- 2002-03-12 AU AU2002240943A patent/AU2002240943B2/en not_active Ceased
- 2002-03-12 WO PCT/EP2002/002691 patent/WO2002072826A2/en not_active Ceased
- 2002-03-12 EP EP02706759A patent/EP1373503B1/en not_active Expired - Lifetime
- 2002-03-12 JP JP2002571881A patent/JP3738008B2/ja not_active Expired - Fee Related
- 2002-03-12 PT PT02706759T patent/PT1373503E/pt unknown
- 2002-03-12 SI SI200230656T patent/SI1373503T1/sl unknown
- 2002-03-12 DK DK02706759T patent/DK1373503T3/da active
- 2002-03-12 PT PT07120461T patent/PT1930439E/pt unknown
- 2002-03-12 DE DE60223511T patent/DE60223511T2/de not_active Expired - Lifetime
- 2002-03-12 AT AT07120461T patent/ATE509103T1/de active
- 2002-03-12 ES ES02706759T patent/ES2296899T3/es not_active Expired - Lifetime
- 2002-03-12 DK DK07120461.4T patent/DK1930439T3/da active
- 2002-03-12 ES ES07120461T patent/ES2366610T3/es not_active Expired - Lifetime
- 2002-03-12 CN CNB028097858A patent/CN1268744C/zh not_active Expired - Fee Related
-
2005
- 2005-02-02 JP JP2005027109A patent/JP2005198656A/ja not_active Withdrawn
-
2011
- 2011-08-10 CY CY20111100765T patent/CY1111750T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1268744C (zh) | 2006-08-09 |
| ATE378353T1 (de) | 2007-11-15 |
| ES2296899T3 (es) | 2008-05-01 |
| JP2005198656A (ja) | 2005-07-28 |
| CA2440767C (en) | 2012-05-29 |
| ES2366610T3 (es) | 2011-10-21 |
| PT1930439E (pt) | 2011-07-25 |
| ATE509103T1 (de) | 2011-05-15 |
| CN1509333A (zh) | 2004-06-30 |
| AU2002240943A2 (en) | 2002-09-24 |
| EP1373503A2 (en) | 2004-01-02 |
| NZ528790A (en) | 2004-06-25 |
| HK1120556A1 (en) | 2009-04-03 |
| DE60223511D1 (de) | 2007-12-27 |
| DK1373503T3 (da) | 2008-03-25 |
| EP1930439B1 (en) | 2011-05-11 |
| AU2002240943B2 (en) | 2007-05-10 |
| JP2004531242A (ja) | 2004-10-14 |
| EP1930439A1 (en) | 2008-06-11 |
| JP3738008B2 (ja) | 2006-01-25 |
| WO2002072826A3 (en) | 2003-04-10 |
| WO2002072826A2 (en) | 2002-09-19 |
| DK1930439T3 (da) | 2011-08-29 |
| SI1373503T1 (sl) | 2008-04-30 |
| CY1111750T1 (el) | 2015-10-07 |
| EP1373503B1 (en) | 2007-11-14 |
| US20020055467A1 (en) | 2002-05-09 |
| DE60223511T2 (de) | 2008-10-23 |
| CA2440767A1 (en) | 2002-09-19 |
| SI1930439T1 (sl) | 2011-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111750T1 (el) | Νευροτροφικοι παραγοντες | |
| SI1095140T1 (sl) | Nevrotrofični dejavniki | |
| IL161016A (en) | Polypeptides capable of ang-2 binding | |
| PT1015585E (pt) | Homologos de ligandos de tie | |
| WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
| WO2003023013A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
| WO2004009834A3 (en) | Novel nucleic acids and secreted polypeptides | |
| WO2003080795A3 (en) | Novel nucleic acids and secreted polypeptides | |
| WO2007045019A3 (en) | Polyoleosins | |
| WO2003025142A3 (en) | Novel nucleic acids and secreted polypeptides | |
| WO2003025134A3 (en) | mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF | |
| WO2002077180A3 (en) | Novel nucleic acids and polypeptides | |
| WO1999053091A3 (de) | Gdnf-kodierende dna, teile davon und gdnf-varianten | |
| EA200100110A1 (ru) | Нейротрофические факторы | |
| WO2001021794A3 (en) | Smad associating polypeptides | |
| WO2001057187A3 (en) | Novel bone marrow nucleic acids and polypeptides | |
| WO2001088091A3 (en) | Novel bone marrow nucleic acids and polypeptides | |
| TW200519206A (en) | Methods for producing novel medaka and novel medaka | |
| WO2004039319A3 (en) | Novel human polypeptides encoded by polynucleotides | |
| WO2001044287A3 (en) | Novel polypeptides and nucleic acids encoding same |